Sun’s Halol gets observations
Sun Pharma’s Halol formulations manufacturing facility in Gujarat, India, is back under US Food and Drug Administration (FDA) scrutiny, after receiving six ‘Form 483’observations.
Sun Pharma’s Halol formulations manufacturing facility in Gujarat, India, is back under US Food and Drug Administration (FDA) scrutiny, after receiving six ‘Form 483’observations.